Invention Grant
- Patent Title: Inhibitors of type 2 vascular endothelial growth factor receptors
- Patent Title (中): 2型血管内皮生长因子受体的抑制剂
-
Application No.: US14071069Application Date: 2013-11-04
-
Publication No.: US09328157B2Publication Date: 2016-05-03
- Inventor: Yan Chen , Elena Getmanova , Martin C. Wright , Alan S. Harris , Ai Ching Lim , Jochem Gokemeijer , Lin Sun , Michael Wittekind
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Main IPC: C07K14/78
- IPC: C07K14/78 ; C07H21/04 ; C12N15/09 ; C07K14/47 ; C07K14/52 ; C07K16/28 ; C07K16/30 ; A61K38/39 ; A61K38/00 ; A61K39/00
Abstract:
The present disclosure relates to novel vascular endothelial growth factor receptor (VEGFR)-binding polypeptides and methods for using these polypeptides to inhibit biological activities mediated by vascular endothelial growth factors (VEGFs). The present disclosure also provides various improvements relating to single domain binding polypeptides.
Public/Granted literature
- US20140179896A1 INHIBITORS OF TYPE 2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS Public/Granted day:2014-06-26
Information query
